Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) is an antibody targeting Apolipoprotein A-II/APOA2. Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) can be used in ELISA, WB, IHC, FC.

Rabbit IgG

4X421

Human

1. Western Blot
-Positive WB detected in: 293T whole cell lysate, A549 whole cell lysate
-All lanes: Apolipoprotein A II antibody at 0.87μg/ml
-Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution
-Predicted band size: 12 KDa
-Observed band size: 12 KDa
2. IHC image of TMAH-00070 diluted at 1:87.5 and staining in paraffin-embedded human liver tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
3. Overlay histogram showing A549 cells stained with TMAH-00070 (red line) at 1:50. The cells were fixed with 70% Ethylalcohol (18h) and then permeabilized with 0.3% Triton X-100 for 2 min. The cells were then incubated in 1x PBS /10% normal goat serum to block non-specific protein-protein interactions followed by primary antibody for 1 h at 4°C. The secondary antibody used was FITC goat anti-rabbit IgG (H+L) at 1/200 dilution for 1 h at 4°C. Control antibody (green line) was used under the same conditions. Acquisition of >10,000 events was performed.

ELISA, WB, IHC, FC

WB:1:500-1:5000; IHC:1:50-1:200.

Monoclonal

Unconjugated

A synthetic peptide: Human APOA2

Human

336

Cardiovascular